Compare FLGT & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLGT | BFST |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.4M | 739.5M |
| IPO Year | 2016 | 2018 |
| Metric | FLGT | BFST |
|---|---|---|
| Price | $23.06 | $29.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $28.33 | ★ $32.75 |
| AVG Volume (30 Days) | ★ 196.7K | 159.3K |
| Earning Date | 02-27-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.03% |
| EPS Growth | N/A | ★ 23.45 |
| EPS | N/A | ★ 2.79 |
| Revenue | ★ $315,549,000.00 | $312,757,000.00 |
| Revenue This Year | $16.84 | $21.90 |
| Revenue Next Year | $9.74 | $4.35 |
| P/E Ratio | ★ N/A | $10.62 |
| Revenue Growth | 13.61 | ★ 19.97 |
| 52 Week Low | $14.57 | $20.07 |
| 52 Week High | $31.04 | $30.32 |
| Indicator | FLGT | BFST |
|---|---|---|
| Relative Strength Index (RSI) | 22.58 | 63.28 |
| Support Level | $22.76 | $29.38 |
| Resistance Level | $26.74 | $30.32 |
| Average True Range (ATR) | 0.82 | 0.78 |
| MACD | -0.47 | 0.17 |
| Stochastic Oscillator | 5.13 | 73.27 |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.